The Role of The Cytomegalovirus Antigenemia Assay in the Detection and Prevention of Cytomegalovirus Syndrome and Disease in Solid Organ Transplant Recipients: A Review of the British Columbia Experience
BACKGROUND: The pp65 cytomegalovirus (CMV) antigenemia assay has been used as a means of guiding the pre-emptive therapy of CMV disease in solid organ transplant (SOT) recipients. Recently, concerns have been raised regarding the utility of the test to accurately and precisely detect viral activity...
Saved in:
Main Authors: | Erica D Greanya, Nilufar Partovi, Eric M Yoshida, R Jean Shapiro, Robert D Levy, Chris H Sherlock, Gwen M Stephens |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2005-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2005/679386 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prophylaxis of Cytomegalovirus in Renal Transplant Recipients
by: Allan S MacDonald, et al.
Published: (1993-01-01) -
Prevention and Treatment of Cytomegalovirus Infection in Transplant Recipients
by: Jutta K Preiksatis
Published: (1993-01-01) -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
by: José Luis Piñana, et al.
Published: (2024-08-01) -
Cytomegalovirus Uveitis with Hypopyon Mimicking Bacterial Endophthalmitis
by: Atsushi Yoshida, et al.
Published: (2015-01-01) -
Cytomegalovirus Pathogenesis in Transplantation
by: Jane E Grundy
Published: (1993-01-01)